Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade
=============================================================================================================================================

* Won Suk Lee
* Dong Sung Kim
* Jeong Hun Kim
* Yoonki Heo
* Hannah Yang
* Eun-Jin Go
* Jin Hyoung Kim
* Seung Joon Lee
* Byung Cheol Ahn
* Jung Sun Yum
* Hong Jae Chon
* Chan Kim